Shaftesbury Capital Plc logo

Shaftesbury Capital Plc (C20)

Market Closed
24 Feb, 11:32
XDUS XDUS
1. 69
+0.06
+3.68%
- Market Cap
60.83 P/E Ratio
- Div Yield
0 Volume
0.71 Eps
1.63
Previous Close
Day Range
1.68 1.69
Year Range
1.26 1.83
Want to track C20 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SHC earnings report is expected in 1 days (26 Feb 2026)

Summary

C20 closed today higher at €1.69, an increase of 3.68% from yesterday's close, completing a monthly increase of 4.32% or €0.07. Over the past 12 months, C20 stock gained 3.68%.
C20 is not paying dividends to its shareholders.
The last earnings report, released on Yesterday at 12:00 AM, missed the consensus estimates by -0.24%. On average, the company has fell short of earnings expectations by -0.13%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

C20 Chart

Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript

Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript

Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript

Seekingalpha | 7 hours ago
Sotera Health (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Sotera Health (SHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 9 hours ago
Sotera Health Company (SHC) Q4 Earnings and Revenues Beat Estimates

Sotera Health Company (SHC) Q4 Earnings and Revenues Beat Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.

Zacks | 10 hours ago

Shaftesbury Capital Plc (C20) FAQ

What is the stock price today?

The current price is €1.69.

On which exchange is it traded?

Shaftesbury Capital Plc is listed on XDUS.

What is its stock symbol?

The ticker symbol is C20.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.24.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Shaftesbury Capital Plc ever had a stock split?

No, there has never been a stock split.

Shaftesbury Capital Plc Profile

Professional Services Industry
Industrials Sector
Michael Petras Jr. CEO
XDUS Exchange
US83601L1026 ISIN
US Country
3,000 Employees
- Last Dividend
- Last Split
20 Nov 2020 IPO Date

Overview

Sotera Health Company specializes in offering critical sterilization, lab testing, and advisory services on both a national and international scale. The company operates its services through three primary segments: Sterigenics, Nordion, and Nelson Labs. Originating as Sotera Health Topco, Inc., the organization rebranded to Sotera Health Company in October 2020, marking its commitment to its expanding capabilities and services. Founded in 2015 and headquartered in Broadview Heights, Ohio, Sotera Health Company plays a pivotal role in various industries including medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials, as well as serving advanced and specialty application industries.

Products and Services

  • Sterilization Services:

    Sotera Health Company provides comprehensive sterilization solutions vital for ensuring the safety and compliance of products in the medical, pharmaceutical, and food industries. These services encompass gamma and electron beam irradiation, alongside ethylene oxide processing. The company's expertise extends to designing, installing, and maintaining gamma irradiation systems, catering to the diverse needs of its clients.

  • Lab Testing Services:

    With a strong focus on ensuring product safety and compliance, the company offers microbiological and analytical chemistry testing services. These are critical in verifying the integrity and efficacy of products, especially in highly regulated industries like pharmaceuticals and food safety.

  • Advisory Services:

    Recognizing the complexities of navigating regulatory landscapes, Sotera Health Company provides clients with technical assistance, regulatory consulting, and advisory services. These services are aimed at helping companies adhere to industry standards and regulations, ensuring their products meet the necessary safety and quality requirements.

Contact Information

Address: 9100 South Hills Boulevard
Phone: 440 262 1410